PharmAla Biotech and Filament Health Announce Release of GMP MDMA Capsules
April 11, 2023 08:00 ET
|
PharmAla Biotech
VANCOUVER, British Columbia, April 11, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”) (CSE:MDMA), a Canadian biotechnology company dedicated to the research and development of...
Societal CDMO Reports Inducement Grants for New Staff
April 06, 2023 16:05 ET
|
Societal CDMO, Inc.
SAN DIEGO and GAINESVILLE, Ga., April 06, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO”; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to...
Harmony Biosciences Holdings Shareholder News: Johnson Fistel Urges Investors with Losses to Reach Out Regarding Class Action Investigation - HRMY
March 28, 2023 19:30 ET
|
Johnson Fistel, LLP
SAN DIEGO, March 28, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY), any of its executive...
Catalyst Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
March 15, 2023 16:11 ET
|
Catalyst Pharmaceuticals, Inc.
Achieved Record 2022 Total Net Revenues of $214 Million, a 52% YoY Increase Achieved FIRDAPSE® Q4 2022 Net Product Revenues of $61 Million, a 59% YoY Increase Newly Acquired FYCOMPA® Product...
Dyspepsia Treatment Market to advancement at a CAGR of 4.1% during 2022–2031, as demand for non-invasive treatment is growing | TMR Study
March 10, 2023 14:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, March 11, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. – In 2021, the Global Dyspareunia Treatment Market size was worth US$ 689.0 Mn. Dyspareunia...
Incannex Engages Catalent for Development and cGMP Manufacture of Psilocybin Drug Product for Clinical Trials and Potential Commercial Use
March 03, 2023 07:30 ET
|
Incannex Healthcare
Highlights: Incannex has engaged Catalent for the development and cGMP manufacture of Incannex’s own psilocybin drug product.The psilocybin is designed for use in Incannex’s ongoing...
PharmAla Biotech named Exclusive MDMA Supply Partner to Awakn Life Sciences
March 02, 2023 08:35 ET
|
PharmAla Biotech
VANCOUVER, British Columbia, March 02, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA), a biotechnology company focused on the research, development, and...
OKYO Pharma Announces Custom Clearance of GMP Packaged OK-101 Drug to be Used in Phase 2 Clinical Trial for Treating Dry Eye Disease
February 28, 2023 02:00 ET
|
OKYO Pharma LTD
LONDON and NEW YORK, Feb. 28, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (LSE: OKYO; NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat dry eye...
Patent Application Published for PharmAla Biotech’s MDMA Analogs
February 23, 2023 08:00 ET
|
PharmAla Biotech
VANCOUVER, British Columbia, Feb. 23, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech (CSE:MDMA) is pleased to announce the publication of a key Patent Cooperation Treaty (PCT) application containing 6...
Tamiflu (Oseltamivir Phosphate) Market to Surpass US$ 978.6 Million by 2030, Says Coherent Market Insights (CMI)
February 20, 2023 10:00 ET
|
CMI
Burlingame, Feb. 20, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, global Tamiflu (oseltamivir phosphate) market is estimated to be valued at US$ 889.2 million in 2022 and is...